The data presented in this study encompass a period of 25 years of clinical records of patients with Fournier's gangrene that had been treated at our center with hyperbaric oxygen therapy.
INTRODUCTION
Fournier's gangrene is a necrotizing fasciitis affecting the genital, perineal and perianal regions and characterized by a polymicrobial origin and for being a progressive disease. It was first described in 1883 by Jean Alfred Fournier, a dermatologist and venereologist, in 5 young and healthy males with an acute and rapidly progressive scrotum gangrene, with no apparent etiology. It is characterized by an obliterating endarteritis that leads to thrombosis of subcutaneous tissue blood vessels, ultimately leading to both skin and vessel gangrene.
1,2
It is a rare disease 2, 3 that predominantly affects males (at a 10 to 1 ratio) with an average age of 50 years. 2, 4 Several predisposing factors have been identified: diabetes, alcoholism, arterial hypertension, renal and hepatic insufficiency, obesity, dementia, tobacco consumption and diseases that affect the immune system such as human immunodeficiency syndrome (HIV), chemo and radiotherapy, cancer and surgical interventions. Concerning etiology, the source can be in the urogenital tract, anorectal region and skin infections. The therapeutic approach to a necrotizing soft tissue infection such as Fournier's gangrene requires a good coordination between surgeon and intensivist. Early surgical debridements are key to a successful treatment, complemented with large spectrum antibiotherapy and supportive care. 1, 7 Hyperbaric oxygen therapy (HBOT) is used as an adjuvant therapy.
1,2,8
HBOT consists in the inhalation 100% O 2 in a pressurized environment -pressure superior to atmospheric pressure (ATM) at sea level -usually at 2 to 3 ATM.
According to the European Committee for Hyperbaric Medicine, HBOT is recommended for anaerobial or mixed bacterial infections (type 1 recommendation, evidence level C).
9
HBOT has anti-infectious effects owing to several mechanisms, including: high O2 levels inside tissues that have bactericide and bacteriostatic effects over certain bacteria, especially in anaerobes; increased phagocytic activity and bacterial lysis by neutrophils; synergism with certain antibiotics is also observed.
10,11
Several studies indicate that the use of HBOT in necrotizing soft tissue infections is associated with an increased survival.
10, [12] [13] [14] The therapeutic protocol ministered at our center consists of HBO sessions at 2.8 ATM for 90 minutes ( Fig.  1 -top) twice daily until the infection is controlled (until 2011 the protocol was 90 minutes of HBO at 2.5 ATM twice daily) followed by HBO daily sessions at 2.5 ATM for 75 minutes until the condition is fully resolved (Fig. 1 -bottom) . In this study, a review of 25 year experience of our center in treating Fournier's gangrene with HBOT is performed.
MATERIAL AND METHODS
This is a retrospective and descriptive study. Clinical records of patients diagnosed with Fournier's gangrene treated with HBOT at Underwater Hyperbaric Medicine Center of the Portuguese Navy, from December 1989 to November 2014, were reviewed. The following parameters were assessed: demographics, etiology, co-morbidities, aggressive surgical debridement (fecal diversion and orchidectomy), microbiology, antibiotherapy, number of HBOT sessions and clinical outcomes.
RESULTS
A total of 34 cases of Fournier's gangrene were treated between December 1989 and November 2014. Patients were mainly from hospitals in Lisbon's metropolitan area. Four of those patients were from hospitals in the periphery Figure 1 -Therapeutic protocol in gas gangrene advocates HBO at 2.8 ATM for 90 minutes, twice daily until sepsis is controlled (Top). At 2.5 ATM sessions, oxygen is administered for 75 minutes (Bottom). 
on a 100 km radius. The mean age of patients was 53.7 years, with a minimum of 19 and a maximum of 82 years. Thirty-two were male (94.1%) and two were female (5.9%).
Of the 21 patients that presented co-morbidities, 13 (corresponding to 61.9%) presented diabetes. Other comorbidities were observed and are presented in Table 1 .
Regarding etiology, out of 18 patients, 7 cases (38.9%) were derived from urinary tract conditions including prostate cancer, prostatitis and orchiepididymitis, 5 cases (27.8%) had their origin in coloproctological diseases like rectal cancer (2 patients), acute diverticulitis (2 patients) and perianal abscess (1 patient) and 3 cases were classified as idiopathic (Table 2 ). Data was not available regarding etiology in the remaining 16 patients.
All patients underwent surgical debridement. In eight patients (23.5%), fecal diversion with colostomy was performed to prevent wound contamination and optimize bandage application. A patient underwent orchidectomy due to extensive surgical debridement. In this retrospective work, we only found microbiological results in 4 patients, namely 2 with β-hemolytic Streptococcus, one with Klebsiella oxytoca and one with Acinetobacter spp.
The most commonly used antibiotics were: metronidazol, clindamycin, meropenem and gentamicin almost always in combination (Table 3 ). The most frequent antibiotic combinations were metronidazol + meropenem and gentamicin + clindamycin.
Out of the 24 patients of which there was information regarding their clinical evolution, 19 (79.2%) survived and were discharged from the hospital and 5 (20.8%) died. Of the patients that passed away, 4 (80%) had been diagnosed with diabetes. After performing a bivariate analysis, no significant correlation (Pearson's correlation coefficient r = -0.266 with p > 0.05, with n = 24) was found between diabetes as comorbidity and death as outcome. We had no access to the clinical evolution of 10 patients.
Surviving patients performed an average of 22.4 sessions (with a standard deviation of 21.6), with a minimum of 6 and maximum of 100 sessions. Fig. 2 shows computed tomography images of a patient with Fournier's gangrene after drainage. The patient presented at emergency department with fever, perineal and abdominal pain. It was found that acute diverticulitis was the origin of his condition. Fig. 3 portrays a patient with Fournier's gangrene in his first HBOT session following drainage (A); after his tenth session (B) and after his twentieth session (C).
Complications related to HBOT were seen in 4 patients, namely middle ear barotrauma in one patient and anxiety in three patients.
DISCUSSION
It was found that the area of residence of patients may affect patients' referral to our center. Owing to the need for differential care and the logistics problems they pose, the access of patients that live furthest from Lisbon would not be possible without affecting other ongoing therapies. The vast majority of patients (94.1%) sent to this center for HBOT came from other hospitals. This fact limited our access to relevant data contained in their clinical reports.
In this review, and in accordance with literature, there was an increased incidence of Fournier's gangrene in males in their sixth decade of life. [2] [3] [4] The most frequent etiology was urinary tract conditions (38.9%) followed by anorectal and colon pathologies (27.8%). These distributions are similar to results obtained in other previous studies.
1,6
Considering microbiological agents usually participating in this type of infections, treatment strategy involves combining broad spectrum antibiotics covering grampositive, gram-negative and anaerobes. Since Fournier's gangrene is an acute and rapidly progressive disease, antibiotics are started expeditiously and empirically, in some cases this takes precedence over collecting material to microbiological testing, which may affect the results. In this work only 4 patients had microbiological results, it was admitted that former antibiotherapy approach and missing information in clinical records may have influenced our search.
Large spectrum antibiotherapy was applied in several combinations, always considering anaerobials, as observed by many works. 1, 8 The number of sessions varied considerably, possibly due to the two distinct therapeutic approaches. On the one hand performing HBOT until achievement of control of acute clinical features, what usually happens in the first week, and, on the other hand, ongoing HBOT in the following weeks to promote wound healing, 10 which can significantly increase the number of needed sessions.
Similarly to previous studies, the most common observed comorbidity was diabetes (61.9% of patients who had comorbidities), suggesting that diabetes is one of the predisposing factors for necrotizing fasciitis and Fournier's gangrene. 1, 6, 15, 16 Although the majority of deceased patients had diabetes (4 out of 5), no significant correlation between diabetes as comorbidity and death was found.
In recent studies, it was found that Fournier's gangrene mortality rate ranges between 16% 4 to 30.8% 17 , namely 17.6% 13 in patients that underwent HBOT. Similarly, in our review, a mortality rate of 20.8%.was observed. 
